About Us: Milestones
Ethicon launches ProPen & ProPen XL products.
Johnson & Johnson Consumer launches BAND-AID® Brand
Liquid Bandage Skin Crack Gel.
Closure receives FDA approval to market its new High-Viscosity
DERMABOND topical skin adhesive.
BAND-AID® Brand Liquid Bandage receives Good Housekeeping’s
“Good Buy” Award.
Closure receives investigational device exemption to commence
vascular sealant pilot study.
Closure medical introduces new DERMABOND delivery devices,
ProPen and ProPen XL.
Closure initiates patient enrollment in FDA-approved pilot
study for its vascular sealant product.
FDA approves new labeling for DERMABOND adhesive to say that
it acts as a barrier to microbial penetration.
Abbott Labs launches NEXABAND® veterinary care product
line in the U.S.
Johnson & Johnson launches BAND-AID® Brand Liquid
Bandage to retail chains in the U.S.
FDA approves LIQUIDERM™ liquid adhesive bandage for
sale in the U.S.
Strategic partnership with Johnson & Johnson Consumer
Products Companies, Inc. is announced to market LIQUIDERM™
liquid adhesive bandage.
Strategic partnership with Abbott Laboratories for NEXABAND®
veterinary care product line is unveiled.
Abbott Labs launches the NEXABAND® veterinary care product
line in the United Kingdom.
DERMABOND adhesive is cleared for market release in Japan.
Announcement of strategic partnership with Colgate for SOOTHE-N-SEAL®
canker sore relief.
SOOTHE-N-SEAL® canker sore relief is approved for market
in the U.S. by the FDA.
An FDA advisory panel unanimously recommends DERMABOND adhesive
DERMABOND adhesive is approved for market in the U.S. by the
DERMABOND adhesive is approved for use in Europe and bears
the CE mark, making it commercially available in 23 countries.
An initial public offering (IPO) puts Closure stock on the
board. Today, you can trade us as CLSR.
Clinical trials for DERMABOND adhesive are successfully completed.
The FDA gives DERMABOND adhesive “expedited processing”
because of the product’s significant public health benefit.